Scott D. Grosse, PhDa, Coleen A. Boyle, PhDa, Aileen Kenneson, PhDa, Muin J. Khoury, MD, PhDb, Benjamin S. Wilfond, MDc
- Serving the family from birth to the medical home: a report from the Newborn Screening Task Force convened in Washington, DC, May 10–11, 1999. Pediatrics. 2000;106:383–427
- Therrell BL Jr. U.S. newborn screening policy dilemmas for the twenty-first century. Mol Genet Metab. 2001;74:64–74
- Levy HL, Albers S. Genetic screening of newborns. Annu Rev Genomics Hum Genet. 2000;1:139–177
- Comeau AM, Larson C, Eaton RB. Integration of new genetic diseases into statewide newborn screening: New England experience. J Med Genet C Semin Med Genet. 2004;125:35–41
- Rinaldo P, Tortorelli S, Matern D. Recent developments and new applications of tandem mass spectrometry in newborn screening. Curr Opin Pediatr. 2004;16:427–433
- National Newborn Screening and Genetics Resource Center. U.S. national screening status report. Available at: http://genes-r-us.uthscsa.edu/nbsdisorders.pdf .
(last accessed 3/2007)
- American College of Medical Genetics. Newborn screening: toward a uniform screening panel and system—report for public comment. Available at: http://mchb.hrsa.gov/screening.
(last accessed 3/2007)
- Bailey DB Jr. Newborn screening for fragile X syndrome. Ment Retard Dev Disabil Res Rev. 2004;10:3–10
- Parsons EP, Clarke AJ, Bradley DM. Developmental progress in Duchenne muscular dystrophy: lessons for earlier detection. Eur J Paediatr Neurol. 2004;8:145–153
- Pass KA, Lane PA, Fernhoff PM, et al. U.S. newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation—statement of the Council of Regional Networks for Genetic Services (CORN). J Pediatr. 2000;137(4 suppl):S1–S46
- Brownson RC, Baker EA, Leet TL, Gillespie KN. Evidence-Based Public Health. New York, NY: Oxford University Press; 2003
- Kohatsu ND, Robinson JG, Torner JC. Evidence-based public health: an evolving concept. Am J Prev Med. 2004;27:417–421
- Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3 suppl):21–35
- Briss PA, Brownson RC, Fielding JE, Zaza S. Developing and using the Guide to Community Preventive Services: lessons learned about evidence-based public health. Annu Rev Public Health. 2004;25:281–302
- Waisbren SE, Mahon BE, Schnell RR, Levy HL. Predictors of intelligence quotient and intelligence quotient change in persons treated for phenylketonuria early in life. Pediatrics. 1987; 79:351–355
- National Research Council. Committee for the Study of Inborn Errors of Metabolism. Genetic Screening: Programs, Principles, and Research. Washington, DC: National Academy of Sciences; 1975
- Clayton EW. What should be the role of public health in newborn screening and prenatal diagnosis? Am J Prev Med. 1999;16:111–115
- Cunningham GC. Two years of PKU testing in California: the role of the laboratory. Calif Med. 1969;110:11–16
- US Congress, Office of Technology Assessment. Healthy Children: Investing in the Future. Washington, DC: US Government Printing Office; 1988
- Hodes RM. Testing newborns for adenosine deaminase deficiency not cost effective. N Engl J Med. 1981;305:1530
- Wall M, Moe E, Eisenberg J, Powers M, Buist N, Buist AS. Long-term follow-up of a cohort of children with alpha-1- antitrypsin deficiency. J Pediatr. 1990;116:248–251
- Consensus Development Conference. Newborn screening for sickle cell disease and other hemoglobinopathies. JAMA. 1987; 258:1205–1209
- Olney RS. Preventing morbidity and mortality from sickle cell disease: a public health perspective. Am J Prev Med. 1999;16: 116–121
- Gaston HH, Verter JJ, Wood G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. N Engl J Med. 1986;314:1593–1599
- Wilson JMG, Jungner G. Principles of Screening for Disease. Geneva, Switzerland: World Health Organization; 1968
- Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG, eds. Assessing Genetic Risks: Implications for Health and Social Policy. Washington, DC: National Academy of Sciences; 1994
- US General Accounting Office. Newborn Screening: Characteristics of State Programs. Washington, DC: Government Printing Office; March 2003. Document GAO-03-449. Available at: http://www.gao.gov/new.items/d03449.pdf
. (last accessed 3/2007)
- Atkinson K, Zuckerman B, Sharfstein JM, Levin D, Blatt RJ, Koh HK. A public health response to emerging technology: expansion of the Massachusetts newborn screening program. Public Health Rep. 2001;116:122–131
- Grosse S, Gwinn M. Assisting states in assessing newborn screening options. Public Health Rep. 2001;116:169–172
- US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996
- Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review. Health Technol Assess. 2004;8(12):1–121
- Advisory Committee on Heritable Disorders and
Genetic Diseases in Newborns and Children: minutes
of second meeting— Washington, DC, September 22–23,
2004.
- Save Babies Through Screening Foundation, Inc. Steps to get supplemental screening. Available at: http://www.savebabies.org/NBS/snbs.php .
(last accessed 3/2007)
- Grosse SD, Boyle CA, Botkin JR, et al. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep. 2004;53(RR-13):1–36
- Baily MA. Final Report: Fairness in the Distribution of Costs and Benefits in Newborn Screening Programs. HRSA contract 01- MCHB-70A with the Hastings Center, Garrison, NY: February, 2003
- Grosse SD. Does newborn screening save money? The difference between cost-effective and cost-saving interventions. J Pediatr. 146:168–170
- Holtzman NA. Routine screening of newborns for cystic fibrosis: not yet. Pediatrics. 1984;73:98–99
- Centers for Disease Control and Prevention. Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development: proceedings of a 1997 workshop. MMWR Recomm Rep. 1997;46(RR-16):1–24
- Farrell PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 2001;107: 1–13
- Koscik RL, Farrell PM, Kosorok MR, et al. Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition. Pediatrics. 2004;113:1549–1558
- Accurso FJ, Sontag MS, Wagener JS. Complications associated with symptomatic diagnosis in infants with cystic fibrosis. J Pediatr. 2005;147(3 suppl):S37–S41
- Ebell MH, Siwek J, Weiss BD, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. J Am Board Fam Pract. 2004; 17:59–67
- Wilfond BS, Gollust SE. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States. J Pediatr. 2005;146:668–674
- Comeau AM, Parad R, Gerstle R, et al. Challenges in implementing a successful newborn cystic fibrosis screening program. J Pediatr. 2005;147(3 suppl):S89–S93
- Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol. 1998; 26:81–88
- Mischler EH, Wilfond BS, Fost N, et al. Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling. Pediatrics. 1998;102:44–52
- Farrell MH, Farrell PM. Newborn screening for cystic fibrosis: ensuring more good than harm. J Pediatr. 2003;143:707–712
- Wilfond BS, Parad RB, Fost N. Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions. J Pediatr. 2005;147(3 suppl):S109–S113
- American Academy of Pediatrics, Committee on Bioethics. Ethical issues with genetic testing in pediatrics. Pediatrics. 2001; 107:1451–1455
- Pelias MK, Markward NJ. Newborn screening, informed consent, and future use of archived tissue samples. Genet Test. 2001;5:179–185
- Mandl KD, Feit S, Larson C, Kohane IS. Newborn screening program practices in the United States: notification, research, and consent. Pediatrics. 2002;109:269–273
- Fant KE, Clark SJ, Kemper AR. Completeness and complexity of information available to parents from newborn-screening programs. Pediatrics. 2005;115:1268–1272
- Leonard JV, Dezateux C. Screening for inherited metabolic disease in newborn infants using tandem mass spectrometry. BMJ. 2002;324:4–5
- Cunningham G. The science and politics of screening newborns. N Engl J Med. 2002;346:1084–1085
- Khoury MJ, Little J. Human genome epidemiologic reviews the beginning of something HuGE. Am J Epidemiol. 2000;151: 2–3
- Lindegren ML, Kobrynski L, Rasmussen SA, et al. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep. 2004;53(RR-1):1–29
- Burke W, Coughlin SS, Lee NC, Weed DL, Khoury MJ. Application of population screening principles to genetic screening for adult-onset conditions. Genet Test. 2001;5:201–211
- Wilfond BS, Nolan K. National policy development for the clinical application of genetic diagnostic technologies: lessons from cystic fibrosis. JAMA. 1993;270:2948–2954
- Agency for Healthcare Research and Quality. Evidence-based practice centers overview. September, 2004. Available at: http://www.ahrq.gov/clinic/epc.
(last accessed 3/2007)
- Campbell E, Ross LF. Parental attitudes regarding newborn screening of PKU and DMD. Am J Med Genet A. 2003;120: 209–214
- American Society of Human Genetics, American College of Medical Genetics. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet. 1995;57:1233–1441
- Ross LF. Predictive genetic testing for conditions that present in childhood. Kennedy Inst Ethics J. 2002;12:225–244
|